These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38019185)

  • 61. Frequency of beta-thalassemia or beta-hemoglobinopathy carriers simultaneously affected with alpha-thalassemia in Iran.
    Alizadeh S; Bavarsad MS; Dorgalaleh A; Khatib ZK; Dargahi H; Nassiri N; Hamid F; Rahim F; Jaseb K; Saki N
    Clin Lab; 2014; 60(6):941-9. PubMed ID: 25016698
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comprehensive screening program for β-thalassemia and other hemoglobinopathies in the Hooghly District of West Bengal, India, dealing with 21 137 cases.
    Bhattacharyya KK; Chatterjee T; Mondal UB
    Hemoglobin; 2016 Nov; 40(6):396-399. PubMed ID: 28276872
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hemoglobinopathy: molecular epidemiological characteristics and health effects on Hakka people in the Meizhou region, southern China.
    Lin M; Wen YF; Wu JR; Wang Q; Zheng L; Liu GR; Huang Y; Yang H; Lin F; Zhan XF; Lin CP; Yang HT; Weng QQ; Huang FT; Wang Y; Yao MQ; Chen HZ; Wu DH; Zeng JB; Zeng RX; Yang H; Li GC; Lu M; Zhu JJ; Xie LX; Wang JL; Yang LY
    PLoS One; 2013; 8(2):e55024. PubMed ID: 23383304
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
    Fattoum S
    Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hemoglobinopathies in the district of Antalya, Turkey.
    Bircan I; Sişli S; Güven A; Cali S; Yeğin O; Ertuğ H; Güven AG; Akar N
    Pediatr Hematol Oncol; 1993; 10(3):289-91. PubMed ID: 8217548
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Newborn screening for hemoglobin disorders.
    Hoppe CC
    Hemoglobin; 2011; 35(5-6):556-64. PubMed ID: 21910601
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye.
    Mohapatra R; Warang P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2016 May; 90(3):279-84. PubMed ID: 25515688
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemoglobinopathies: An update on the prevalence trends in Southern Saudi Arabia.
    Makkawi M; Alasmari S; Hawan AA; Shahrani MMA; Dera AA
    Saudi Med J; 2021 Jul; 42(7):784-789. PubMed ID: 34187923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thalassemia and hemoglobinopathy prevalence in a community-based sample in Sylhet, Bangladesh.
    Wendt AS; Brintrup J; Waid JL; Kader A; Lambrecht NJ; Gabrysch S
    Orphanet J Rare Dis; 2023 Jul; 18(1):192. PubMed ID: 37468973
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness of Prenatal Screening for Hemoglobinopathies in a Developing Country.
    Choudhuri S; Sen A; Ghosh MK; Misra S; Bhattacharyya M
    Hemoglobin; 2015; 39(6):380-3. PubMed ID: 25970198
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparing prenatal and neonatal diagnosis of hemoglobinopathies.
    Schoen EJ; Marks SM; Clemons MM; Bachman RP
    Pediatrics; 1993 Sep; 92(3):354-7. PubMed ID: 8361789
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan.
    Peng CT; Liu SC; Peng YC; Lin TH; Wang SJ; Le CY; Shih MC; Tien N; Lu JJ; Lin CY
    Blood Cells Mol Dis; 2013 Oct; 51(3):138-41. PubMed ID: 23689197
    [TBL] [Abstract][Full Text] [Related]  

  • 73. β-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: results from a single center study.
    Guvenc B; Canataroglu A; Unsal C; Yildiz SM; Turhan FT; Bozdogan ST; Dincer S; Erkman H
    Arch Med Sci; 2012 Jul; 8(3):411-4. PubMed ID: 22851993
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Beta-, delta beta-thalassemia and Hb lepore among Yugoslav, Bulgarian, Turkish and Albanian.
    Efremov GD
    Haematologica; 1990; 75 Suppl 5():31-41. PubMed ID: 2086380
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme.
    Al-Allawi NA; Al-Dousky AA
    East Mediterr Health J; 2010 Apr; 16(4):381-5. PubMed ID: 20795420
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Where we are in the fight against Hepatitis B Infection; Trends in Hepatitis B virus seroprevalence in Black Sea Region of Turkey.
    Igde FA; Taskin H; Igde M; Yazici Z; Atilla A
    Niger J Clin Pract; 2018 Jan; 21(1):87-92. PubMed ID: 29411730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Hemoglobin variants in Colombian patients referred to discard hemoglobinopathies].
    Romero-Sánchez C; Gómez Gutiérrez A; Duarte Y; Amazo C; Manosalva C; Chila M L; Casas-Gómez MC; Briceño Balcázar I
    Rev Med Chil; 2015 Oct; 143(10):1260-8. PubMed ID: 26633269
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of hemoglobinopathy disorders in adult patients sent for diagnosis of anemia in saudi arabia.
    Alsaeed AH
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):25-9. PubMed ID: 21861712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
    Voskaridou E; Ntanasis-Stathopoulos I; Christoulas D; Dimopoulou M; Komninaka V; Repa K; Papatheodorou A; Terpos E
    Ann Hematol; 2019 Jul; 98(7):1583-1592. PubMed ID: 31041514
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Study of hemoglobinopathy in Kashi district of Xinjiang].
    Yu W; Zhang Z; Li H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):198-200. PubMed ID: 11243136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.